Facebook
Linkedin
Mail
X
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
X
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: Bayer
Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary artery disease
2nd August 2018
The Committee for Medicin...
ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and myocardial infarction in patients with coronary artery disease
4th September 2017
The COMPASS study, wh...
AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients with atrial fibrillation
18th November 2016
Two drug regimens inv...
